Professor Brendan Keating’s lab focuses on “advancing the field of organ transplantation” and employs multiomic techniques to improve outcomes for both allo- (human to human) and xeno- (animal to human) transplantation. He’s using multiomics to better understand the mechanisms of rejection and acceptance with a particular focus on immunologic barriers in cross-species transplantation. Professor Keating joins Translating Proteomics to discuss:

  • The current state of transplant medicine including xenotransplantation
  • How multiomics is changing transplant medicine
  • The future of transplant medicine.


Chapters:

00:00 – Introduction

05:00 - Transplantation Today: Outcomes, Challenges, and the Organ Shortage

10:06 - From Genetics to Multiomics

19:53 - Xenotransplantation deep dive

30:42 - Ten‑Year Vision: Transplants and the Role of Multiomics

Podden och tillhörande omslagsbild på den här sidan tillhör Nautilus Biotechnology. Innehållet i podden är skapat av Nautilus Biotechnology och inte av, eller tillsammans med, Poddtoppen.